TITLE

Historical Perspectives in Postmenopausal Hormone Therapy: Defining the Right Dose and Duration

AUTHOR(S)
Warren, Michelle P.
PUB. DATE
February 2007
SOURCE
Mayo Clinic Proceedings;Feb2007, Vol. 82 Issue 2, p219
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Recommended dosages of postmenopausal estrogen therapy (ET) and estrogen-progestin therapy (EPT), like those of oral contraceptives, have decreased markedly since oral estrogens were first Introduced. Recently, the movement toward lower doses of ET/ EPT has accelerated because of the results of the Women's Health initiative, which showed that lower-dose ET/EPT may provide similar efficacy and an Improved safety profile compared with higher-dose preparations. For example, lower ET/EPT doses effectively relieve vasomotor and vulvovaginal symptoms associated with menopause, prevent bone loss, protect the endometrium, and are better tolerated than commonly prescribed doses. Current guidelines suggest the use of the lowest effective dose for the shortest duration consistent with treatment goals, benefits, and risks for the individual woman. However, the impact of treatment discontinuation should be considered when advising women to use hormone therapy for relieving menopausal symptoms for the shortest possible duration.
ACCESSION #
24013421

 

Related Articles

  • The Anabolic Effects of Growth Hormone (GH) and GH Secretagogues on Bone Mass and Density. Svensson, Johan // Medicinal Chemistry Reviews - Online;Feb2005, Vol. 2 Issue 1, p1 

    Several antiresorptive agents have been developed for the treatment of osteoporosis and bone disorders. Few agents have been introduced that stimulate bone formation. Treatment with parathyroid hormone induces, however, a potent increase in hip and lumbar bone mineral density (BMD) and is now...

  • A new verdict for hormone therapy: Safe for younger women. Knotts, Janie L.; Childers Jr, William A. // JAAPA: Journal of the American Academy of Physician Assistants (;Dec2009, Vol. 22 Issue 12, p46 

    The article cites the studies providing up-to-date information about hormone therapy (HT). It describes the current recommendations for the use of HT, including its risks and potential benefits. It examines the routes of administration and dosing regimens for HT, including duration of and when...

  • Mrs Ill's grips are put in Kenyan perspective. Selby, Mary // GP: General Practitioner;9/12/2008, p26 

    The article discusses the comparison of Mr. Ali of Kenya and Mrs. Ill case. She cites that Ali rents the glass-bottom boat of his brother for the medicine that costs £35 for the lump at his neck. The author ponders on the case of Mrs. Ill, a well woman decided to have weak immune system,...

  • For Lingering Questions About Hormone Therapy.  // Tufts University Health & Nutrition Letter;Nov2003, Vol. 21 Issue 9, p2 

    Reports on the health risk from prolonged use of hormone therapy. Details of the right dose and the right amount of time to take hormone drugs according to the U.S. Food and Drug Administration; Campaign started by the agency to help women grappling with hormone therapy decisions.

  • Tailoring Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A CYP2D6 Multiple-Genotype-Based Modeling Analysis and Validation. Ke-Da Yu; A-Ji Huang; Zhi-Ming Shao // PLoS ONE;2010, Vol. 5 Issue 12, p1 

    Purpose: Previous studies have suggested that postmenopausal women with breast cancer who present with wild-type CYP2D6 may actually have similar or superior recurrence-free survival outcomes when given tamoxifen in place of aromatase inhibitors (AIs). The present study established a CYP2D6...

  • What to Do when being Aged by Culture. Gullette, Margaret Morganroth // Tikkun;Jul/Aug2003, Vol. 18 Issue 4, p63 

    Deals with the effects of the use of hormone replacement therapy (HRT) by women. Dangers caused by HRT; Reasons that women have been convinced to take HRT for so long; Background on the HRT boom of the 1990s.

  • Low dose oestrogen and osteoporosis prevention. Heikkinen, Jorma // Journal of the British Menopause Society;2000 Supplement, Vol. 6, p12 

    The article presents information on low dose oestrogen and its contribution to the prevention of osteoporosis. The low-dose continuous combined therapy of hormone replacement therapy is explored as it shows the potential to be better tolerated by patients. Studies show that lower doses of...

  • Optimising care: an introduction. Mattsson, Lars-Åke // Journal of the British Menopause Society;2000 Supplement, Vol. 6, p4 

    The article discusses the optimization of care in the benefits and risks associated with hormone replacement therapy (HRT). Physicians are challenged to inform women clearly about such details and to offer individualized treatment. Resumption of bleeding episodes has proven to be a major factor...

  • Hot Flashes and Androgens: A Biological Rationale for Clinical Practice. Notelovitz, Morris // Journal of Family Practice;May2004 Supplement, Vol. 53, p5 

    Menopause-related hot flashes are usually treated with a standardized dose of estrogen. This general approach to the most prevalent menopausal symptom is predicated on the belief that all menopausal women will respond to a uniform dose of estrogen, irrespective of the type or route of...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics